PubRank

D J Moss

Author PubWeight™ 148.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997 4.65
2 Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 1992 3.75
3 Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 1978 2.81
4 Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res 1981 2.74
5 Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med 1994 2.47
6 An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J Exp Med 1990 2.44
7 Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J Gen Virol 1972 2.18
8 An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994 2.02
9 The specificity of recognition of a cytotoxic T lymphocyte epitope. Eur J Immunol 1992 1.98
10 Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 1995 1.90
11 Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc Natl Acad Sci U S A 1999 1.82
12 An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. J Virol 1990 1.79
13 Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci U S A 1990 1.74
14 Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. Int J Cancer 1985 1.62
15 HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc Natl Acad Sci U S A 1980 1.60
16 New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 1987 1.58
17 HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998 1.58
18 T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 1995 1.56
19 Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 1979 1.51
20 Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro. Int J Cancer 1984 1.37
21 Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology 1989 1.35
22 Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J Gen Virol 1994 1.35
23 Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. J Immunol 1997 1.34
24 Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J Virol 1984 1.32
25 Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro. Eur J Immunol 1981 1.30
26 Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells. Immunology 1991 1.30
27 Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Virology 1995 1.27
28 Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J Virol 1996 1.27
29 Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 1990 1.26
30 Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J Virol 1997 1.25
31 Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J Immunol 1998 1.21
32 Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997 1.20
33 Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies. Proc Natl Acad Sci U S A 1991 1.20
34 Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 2001 1.18
35 T lymphocytes in infectious mononucleosis. I. T cell death in vitro. Clin Exp Immunol 1985 1.17
36 Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients. Int J Cancer 1980 1.16
37 X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol 1999 1.15
38 Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours. Neuropathol Appl Neurobiol 2007 1.15
39 Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med 1996 1.15
40 Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc Natl Acad Sci U S A 1995 1.14
41 A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int J Cancer 1983 1.13
42 Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants. Eur J Immunol 1981 1.12
43 Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature 1981 1.11
44 Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology 1992 1.10
45 Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. Cancer Res 1998 1.10
46 Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int J Cancer 1981 1.09
47 Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection. Blood 2001 1.09
48 Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol 1994 1.08
49 Cell relationships in transformation of human leukocytes by Epstein-Barr virus. Int J Cancer 1974 1.07
50 Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J Immunol 1996 1.07
51 Induction of Epstein-Barr virus nuclear antigens. J Virol 1986 1.06
52 Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma. IARC Sci Publ 1985 1.06
53 On-chip CMOS-compatible all-optical integrator. Nat Commun 2010 1.03
54 Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 1979 1.02
55 Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing. Int Immunol 1997 1.00
56 Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J Virol 1996 0.99
57 Demonstration of a stable ultrafast laser based on a nonlinear microcavity. Nat Commun 2012 0.99
58 Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition. J Biol Chem 2001 0.99
59 Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). Int J Cancer 1974 0.99
60 A family of glycoproteins (GP55), which inhibit neurite outgrowth, are members of the Ig superfamily and are related to OBCAM, neurotrimin, LAMP and CEPU-1. J Cell Sci 1996 0.99
61 T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv 1992 0.98
62 Human lymphoid cell transformation by Epstein-Barr virus. Nat New Biol 1973 0.98
63 Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J Virol 1996 0.97
64 A neuronal surface glycoprotein associated with the cytoskeleton. J Cell Biol 1984 0.96
65 Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation. Immunol Rev 1999 0.96
66 Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Cell Immunol 1991 0.95
67 Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection. J Immunol Methods 1993 0.95
68 Distance measurement between the active site and cysteine-177 of the alkali one light chain of subfragment 1 from rabbit skeletal muscle. Biochemistry 1983 0.94
69 Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients. Int J Cancer 1983 0.93
70 Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. Int Immunol 1994 0.93
71 T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines. Clin Exp Immunol 1985 0.93
72 Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res Hum Retroviruses 1992 0.93
73 Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J Virol 1995 0.93
74 Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response. Cell Immunol 1982 0.92
75 Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1. Virology 1996 0.92
76 Identification of a novel protein from adult chicken brain that inhibits neurite outgrowth. J Cell Sci 1994 0.92
77 A comparison of Epstein-Barr virus-specific T-cell immunity in rheumatoid arthritis and osteoarthritis patients. Aust J Exp Biol Med Sci 1983 0.92
78 A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunol Immunother 1997 0.92
79 Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. J Immunol 1997 0.92
80 The influence of antiviral T-cell responses on the alloreactive repertoire. Immunol Today 1999 0.91
81 Co-localisation, heterophilic interactions and regulated expression of IgLON family proteins in the chick nervous system. Brain Res Mol Brain Res 2000 0.91
82 Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation. Cell Immunol 1982 0.91
83 Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines. J Virol 1997 0.90
84 A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J Clin Invest 1998 0.90
85 Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design. J Virol 1998 0.90
86 Human malignant melanoma cell lines. Pathology 1979 0.90
87 EB Virus-associated nuclear antigen production and cell proliferation in adult peripheral blood leukocytes inoculated with the QIMR-WIL strain of EB virus. Int J Cancer 1975 0.89
88 Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies. Tissue Antigens 2004 0.89
89 Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. J Virol 1996 0.88
90 Low power four wave mixing in an integrated, micro-ring resonator with Q = 1.2 million. Opt Express 2009 0.87
91 Amorphous silicon nanowires combining high nonlinearity, FOM and optical stability. Opt Express 2012 0.87
92 Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus. Int J Cancer 1984 0.87
93 Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design. Vaccine 2001 0.87
94 Detection of Epstein-Barr virus strain variants in lymphoblastoid cell lines 'spontaneously' derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls. J Gen Virol 1987 0.87
95 Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection. Int Immunol 1997 0.86
96 Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing. J Exp Med 1996 0.86
97 EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. J Immunol 1993 0.86
98 Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells. Int J Cancer 1998 0.85
99 A developmentally regulated chicken neuronal protein associated with the cortical cytoskeleton. J Neurosci 1989 0.85
100 Error-free all-optical demultiplexing at 160Gb/s via FWM in a silicon nanowire. Opt Express 2010 0.84
101 Cytoskeleton-associated glycoproteins from chicken sympathetic neurons and chicken embryo brain. Eur J Biochem 1983 0.84
102 BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays. J Immunol Methods 1991 0.84
103 Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3. J Gen Virol 1991 0.83
104 Identification and characterization of CEPU-Se-A secreted isoform of the IgLON family protein, CEPU-1. Mol Cell Neurosci 2001 0.83
105 Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen. Clin Exp Immunol 1992 0.82
106 Optical signal processing on a silicon chip at 640Gb/s using slow-light. Opt Express 2010 0.82
107 Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters. Int Immunol 2001 0.81
108 Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression. Oncogenesis 2012 0.81
109 Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. J Immunol 1993 0.80
110 Spontaneous apoptosis in NS-1 myeloma cultures: effects of cell density, conditioned medium and acid pH. Immunobiology 1993 0.80
111 Cost-efficient quantification of enzyme-linked immunospot. Biotechniques 2001 0.80
112 All-optical XOR logic gate for 40Gb/s DPSK signals via FWM in a silicon nanowire. Opt Express 2011 0.80
113 Differential splicing of antigen-encoding RNA reduces endogenous epitope presentation that regulates the expansion and cytotoxicity of T cells. J Immunol 2000 0.79
114 Characterisation of a soluble trypsin fragment of GP130: a neuronal glycoprotein associated with the cytoskeleton. J Cell Biochem 1986 0.79
115 High-level expression of recombinant Fc chimeric proteins in suspension cultures of stably transfected J558L cells. Biotechniques 2002 0.78
116 Solar and UVC-induced mutation in human cells and inhibition by deoxynucleosides. Mutat Res 1989 0.78
117 An immunological basis for inhibition of transformation of human lymphocytes by EB virus. Nature 1977 0.78
118 Interleukin-2 receptors in infectious mononucleosis. Immunol Lett 1989 0.78
119 cDNA cloning of the CEPUS, a secreted type of neural glycoprotein belonging to the immunoglobulin-like opioid binding cell adhesion molecule (OBCAM) subfamily. Mol Cells 1999 0.78
120 Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells. J Invest Dermatol 1988 0.78
121 Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants. J Virol 1996 0.77
122 Actin polymerization and synthesis in cultured neurones. Exp Cell Res 1983 0.77
123 Expression of p53, bcl-2, bax, bcl-x2 and c-myc in radiation-induced apoptosis in Burkitt's lymphoma cells. Cell Death Differ 1996 0.77
124 Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro. Scand J Immunol 1991 0.77
125 Candidate vaccines for Epstein-Barr virus. BMJ 1998 0.77
126 GP55 inhibits both cell adhesion and growth of neurons, but not non-neuronal cells, via a G-protein-coupled receptor. Eur J Neurosci 1997 0.76
127 Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells. Pigment Cell Res 1989 0.76
128 Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells. Int J Cancer 1990 0.76
129 T lymphocyte lines from arthritic synovial fluid: establishment and function. Ann Rheum Dis 1986 0.75
130 Familial Burkitt's lymphoma in Papua New Guinea. Br J Cancer 1997 0.75
131 Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell lines. Int J Cancer 1985 0.75
132 Mid-infrared nonlinear optical response of Si-Ge waveguides with ultra-short optical pulses. Opt Express 2015 0.75
133 No barrier to diffusion between cell soma and neurite membranes in sympathetic neurons for a GPI-anchored glycoprotein. Mol Cell Neurosci 2003 0.75
134 Substrate-bound GP130/F11 will promote neurite outgrowth: evidence for a cell surface receptor. Eur J Cell Biol 1993 0.75
135 Inhibition of HLA B8-restricted recognition by unrelated peptides: evidence for allosteric inhibition. Immunol Lett 1991 0.75
136 Dispersion in the anisotropy of optical third-harmonic generation in silicon. Opt Lett 1989 0.75
137 Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism. Blood 1999 0.75
138 Two-photon absorption effects on Raman gain in single mode As2Se3 chalcogenide glass fiber. Opt Express 2008 0.75
139 Two-photon photodetector in a multiquantum well GaAs laser structure at 1.55 microm. Opt Express 2009 0.75
140 Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants. Cell Immunol 1990 0.75
141 Identity of the soluble EBV-associated antigens of human lymphoid cell lines. Int J Cancer 1972 0.75
142 All-optical wavelength conversion for 10 Gb/s DPSK signals in a silicon ring resonator. Opt Express 2011 0.75
143 Identification of chURP, a nuclear calmodulin-binding protein related to hnRNP-U. Eur J Biochem 1999 0.75
144 Inhibition of EB virus transformation of non-adherent human lymphocytes by co-cultivation with adult fibroblasts. Med Microbiol Immunol 1976 0.75
145 High bit rate all-optical signal processing in a fiber photonic wire. Opt Express 2008 0.75
146 T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cells. Immunol Cell Biol 1989 0.75
147 Characterization of a novel monoclonal antibody, 3H-1, reactive with squamoproliferative lesions and squamous-cell cancers. Int J Cancer 1991 0.75
148 Nonlinear optical response of low loss silicon germanium waveguides in the mid-infrared. Opt Express 2015 0.75
149 Sexually transmitted diseases in college men: a preliminary clinical investigation. J Am Coll Health 1993 0.75
150 Prognostic significance of monoclonal antibody 3H-1 reactivity with squamous-cell head-and-neck cancers. Int J Cancer 1991 0.75
151 Atmospheric carbon dioxide, the southern oscillation, and the weak 1975 el nino. Science 1980 0.75
152 Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation. IARC Sci Publ 1978 0.75